Pulmonx Corporation LUNG
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.54% | -8.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.54% | -8.90% | |||
| Cost of Revenue | 10.39% | -10.18% | |||
| Gross Profit | 10.58% | -8.53% | |||
| SG&A Expenses | -9.69% | 5.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.15% | 3.20% | |||
| Operating Income | 30.09% | -30.83% | |||
| Income Before Tax | 26.35% | -31.90% | |||
| Income Tax Expenses | -10.74% | -19.89% | |||
| Earnings from Continuing Operations | 26.18% | -30.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.18% | -30.97% | |||
| EBIT | 30.09% | -30.83% | |||
| EBITDA | 31.17% | -34.10% | |||
| EPS Basic | 27.16% | -29.43% | |||
| Normalized Basic EPS | 27.34% | -30.34% | |||
| EPS Diluted | 27.16% | -29.43% | |||
| Normalized Diluted EPS | 27.34% | -30.34% | |||
| Average Basic Shares Outstanding | 1.36% | 1.19% | |||
| Average Diluted Shares Outstanding | 1.36% | 1.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||